MENU
RNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rein Therapeutics (RNTX) Earnings Date & Reports
Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments... Show more
A.I. Advisor
published Earnings
RNTX is expected to report earnings to -10 cents per share on November 13
Q3'26
Est.
$-0.10
Q2'26
Beat
by $0.39
Q4'25
Missed
by $0.92
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.07
The last earnings report on August 14 showed earnings per share of -10 cents, beating the estimate of -49 cents. With 215.46K shares outstanding, the current market capitalization sits at 51.97M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
12407 North Mopac Expressway
Phone
+1 737 802-1989
Employees
10
Web
https://www.reintx.com